| Reconciliation of Cash, Cash Equivalents and Restricted Cash |
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
2018 |
|
2017 |
Consolidated balance sheets |
|
|
|
|
|
Cash and cash equivalents |
$ |
37,379 |
|
$ |
114,882 |
Restricted cash included in |
|
|
|
|
|
Land and building held for development |
|
1,088 |
|
|
1,088 |
Consolidated statements of cash flows |
$ |
38,467 |
|
$ |
115,970 |
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
2019 |
|
2018 |
Consolidated balance sheets |
|
|
|
|
|
Cash and cash equivalents |
$ |
6,749 |
|
$ |
8,687 |
Restricted cash included in |
|
|
|
|
|
Land and building held for development |
|
1,088 |
|
|
1,088 |
Consolidated statements of cash flows |
$ |
7,837 |
|
$ |
9,775 |
|
| Calculation Of Earnings Per Share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For The Three Months |
|
For The Nine Months |
|
Ended September 30, |
|
Ended September 30, |
|
2019 |
|
2018 |
|
2019 |
|
2018 |
Calculation of net income allocable to common shareholders |
|
|
|
|
|
|
|
|
|
Net income |
$ |
46,510 |
|
$ |
44,843 |
|
$ |
142,458 |
|
$ |
218,727 |
Net (income) loss allocated to |
|
|
|
|
|
|
|
|
|
|
|
Preferred shareholders based upon distributions |
|
(12,959) |
|
|
(12,959) |
|
|
(38,877) |
|
|
(38,921) |
Noncontrolling interests—joint venture |
|
(14) |
|
|
189 |
|
|
(27) |
|
|
1,008 |
Restricted stock unit holders |
|
(219) |
|
|
(239) |
|
|
(699) |
|
|
(1,592) |
Net income allocable to common shareholders |
|
|
|
|
|
|
|
|
|
|
|
and noncontrolling interests—common units |
|
33,318 |
|
|
31,834 |
|
|
102,855 |
|
|
179,222 |
Net income allocation to noncontrolling interests— |
|
|
|
|
|
|
|
|
|
|
|
common units |
|
(7,006) |
|
|
(6,703) |
|
|
(21,643) |
|
|
(37,822) |
Net income allocable to common shareholders |
$ |
26,312 |
|
$ |
25,131 |
|
$ |
81,212 |
|
$ |
141,400 |
|
|
|
|
|
|
|
|
|
|
|
|
Calculation of common partnership units as a percentage of common share equivalents |
|
Weighted average common shares outstanding |
|
27,432 |
|
|
27,339 |
|
|
27,411 |
|
|
27,310 |
Weighted average common partnership units outstanding |
|
7,305 |
|
|
7,305 |
|
|
7,305 |
|
|
7,305 |
Total common share equivalents |
|
34,737 |
|
|
34,644 |
|
|
34,716 |
|
|
34,615 |
Common partnership units as a percentage of common |
|
|
|
|
|
|
|
|
|
|
|
share equivalents |
|
21.0% |
|
|
21.1% |
|
|
21.0% |
|
|
21.1% |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
Basic weighted average common shares outstanding |
|
27,432 |
|
|
27,339 |
|
|
27,411 |
|
|
27,310 |
Net effect of dilutive stock compensation—based on |
|
|
|
|
|
|
|
|
|
|
|
treasury stock method using average market price |
|
111 |
|
|
103 |
|
|
101 |
|
|
102 |
Diluted weighted average common shares outstanding |
|
27,543 |
|
|
27,442 |
|
|
27,512 |
|
|
27,412 |
|